what was the first glp 1 agonist are GLP-1s? What is GLP-1 and Its
Description
Semaglutide was removed in February 2025
Limited evidence suggests that combined SGLT2is/GLP1-RAs therapy can potentially improve most but not all outcomes
See if you qualify for compensation and how to file.
However, because federal law does not require state-licensed pharmacies that are not outsourcing facilities to submit adverse events to FDA, many cases are likely going undocumented.FDA has also warned companies that have illegally sold unapproved drugs containing semaglutide, tirzepatide or retatrutide that are falsely labeled for research purposes or not for human consumption. These products have been sold directly to consumers for human use with dosing instructions
The clinical results so far are hard to ignore
Understanding these conflicts helps ensure safe, successful treatment with semaglutide or tirzepatide
